We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 530

Biotechnological inventions in India: law, practice and challenges
  • Remfry & Sagar
  • India
  • October 23 2015

Indian patent filing and jurisprudence in the biotech domain have seen neither the volume nor the attention enjoyed by the pharmaceuticals and

Prior registration of a mark is of no assistance if the use of the same is commenced after twelve year
  • Khaitan & Co
  • India
  • October 13 2015

The Supreme Court of India (Supreme Court), giving credence to the 'first in the market' test, has passed a significant decision in the case of Neon

Competition law as panacea for high prices?
  • Bristows LLP
  • European Union, India, United Kingdom
  • October 12 2015

It seems that the CMA's opening of an investigation into Pfizer Flynn (which we discussed here) may not be the only pending competition case on

Sun Pharma v Psycoremedies
  • RNA, Intellectual Property Attorneys
  • India
  • October 7 2015

Madras High Court considers impact of twelve years of use and co-existence to set aside the ex parte interim injunction granted on the basis of prior

A review of recent patent opposition cases
  • RNA, Intellectual Property Attorneys
  • India
  • September 24 2015

Opponents in patents opposition cases in the life sciences are now actively relying on grounds of non-patentable invention, under section 3 of the

Pfizer’s Patent Application relating to rheumatoid arthritis drug (Tofacitinib) rejected by Indian patent
  • Khaitan & Co
  • India
  • September 9 2015

The Indian Patent Office (IPO) has passed an order on 3 September 2015 (Order) rejecting patent application no. 991MUMNP2003 (Patent Application

Symed Labs wins process patent protection at Delhi High Court
  • RNA, Intellectual Property Attorneys
  • India
  • July 8 2015

Symed Labs invented a new process for preparation of Linezolid as compared to the earlier existing processes which were tedious and cumbersome. Symed

Compulsory license for AstraZeneca’s diabetes management drug Saxagliptin?
  • Khaitan & Co
  • India
  • July 7 2015

In a recent development, a compulsory license (CL) application has been filed for the patent covering AstraZeneca's diabetes management drug

Phonetic similarity is the key - court holds GENTAC similar to ZANTAC and ZINETAC
  • RNA, Intellectual Property Attorneys
  • India
  • July 2 2015

Glaxo Group Ltd being aggrieved with Systochem Lab’s use of the brand GENTAC for gastro medicines initiated an action against them before the Delhi

Helping the generic market: the Bolar exemption
  • LexOrbis Consulting Pvt Ltd
  • India
  • June 17 2015

A lot of water has flowed under the bridge since the United States enacted the Drug Price Competition and Patent Term Restoration Act 1984, commonly